MRI scans could revolutionize how we measure muscular dystrophy

NCT ID NCT01484678

Recruiting now Knowledge-focused Sponsor: University of Florida Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses MRI scans to track muscle damage and fat buildup in boys and men with Duchenne or Becker muscular dystrophy over 5-10 years. Researchers will compare these images with how well participants can walk and perform daily activities. The goal is to find better ways to measure disease progression in future clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide better ways to measure disease progression in muscular dystrophy, helping future trials test treatments more effectively.
What could go wrong: This is an observational study, not testing a treatment. It may not lead directly to new therapies, and results depend on long-term participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BECKER MUSCULAR DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Becker muscular dystrophy Duchenne muscular dystrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BECKER MUSCULAR DYSTROPHY DUCHENNE MUSCULAR DYSTROPHY

Contacts and locations

Locations

Children's Hospital of Philadelphia
ACTIVE_NOT_RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Oregon Health and Science University
RECRUITING

Portland, Oregon, 97239, United States
University of Florida
RECRUITING

Gainesville, Florida, 32610, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.